Eteplirsen approved in US for treatment of duchenne muscular dystrophy

Science Daily

The U.S. Food and Drug Administration has decided to grant accelerated approval for eteplirsen, the first disease-modifying drug to treat the most common childhood form of muscular dystrophy.

view Science Daily